Spruce Biosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SPRB and other ETFs, options, and stocks.About SPRB
Spruce Biosciences, Inc. is a biopharmaceutical company, which engages in developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need. The company was founded on November 13, 2014 and is headquartered in South San Francisco, CA.
CEOJavier Szwarcberg
CEOJavier Szwarcberg
Employees21
Employees21
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2014
Founded2014
Employees21
Employees21
SPRB Key Statistics
Market cap113.93M
Market cap113.93M
Price-Earnings ratio-1.23
Price-Earnings ratio-1.23
Dividend yield—
Dividend yield—
Average volume207.75K
Average volume207.75K
High today$110.00
High today$110.00
Low today$101.31
Low today$101.31
Open price$103.00
Open price$103.00
Volume65.46K
Volume65.46K
52 Week high$240.00
52 Week high$240.00
52 Week low$4.28
52 Week low$4.28
Stock Snapshot
Spruce Biosciences(SPRB) stock is priced at $104.57, giving the company a market capitalization of 113.93M. It carries a P/E multiple of -1.23.
As of 2025-11-26, Spruce Biosciences(SPRB) stock has fluctuated between $101.31 and $110.00. The current price stands at $104.57, placing the stock +3.2% above today's low and -4.9% off the high.
The Spruce Biosciences(SPRB)'s current trading volume is 65.46K, compared to an average daily volume of 207.75K.
During the past year, Spruce Biosciences(SPRB) stock moved between $4.28 at its lowest and $240.00 at its peak.
During the past year, Spruce Biosciences(SPRB) stock moved between $4.28 at its lowest and $240.00 at its peak.
People also own
Based on the portfolios of people who own SPRB. This list is generated using Robinhood data, and it’s not a recommendation.